Announcing the Next in Naturals QuickFire Challenge on Immune-Support

June 23, 2020 -
22 days ago
Other news

Naturals%20Immune%20Support%20-%20Tweet%20Cards.jpg

Families often turn to dietary supplements inspired by nature with ingredients such as ElderberryVitamin C, and Zinc with the aim to help safely support their immune systems. A heightened awareness for the need to support your immune system throughout the year has resulted in an increased demand for products with immune-supporting and wholesome ingredients.*

To that end, Johnson & Johnson Innovation is launching the Next in Naturals QuickFire Challenge on Immune-Support, calling on innovators to submit potential solutions inspired by nature that aim to support healthy immune systems in babies, children, or adults. Ideas for dietary supplements should be supported by scientific data, including:

  • Products inspired by nature that fit within the traditional Immune Support space and either contain unique ingredients or come in unique product forms
  • Natural-based wellness potential solutions in areas beyond traditional Immune Support including gut health, vitamins, etc.

Ingredients and vehicles for delivery that are backed by non-confidential pre-clinical / clinical data are preferred but not required (could be references to existing literature) Product should be available for commercialization in existing retail channels within 6-18 months.

The innovator(s) with the best idea(s) will receive up to $50,000 in grant funding, one year of residency at an available JLABS, and the opportunity to engage with leadership from Johnson & Johnson Innovation.

About Johnson & Johnson Innovation 

Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation JLABS; JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com .

About Johnson & Johnson Innovation - JLABS

Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS. 

 

* Nielsen U.S. xAOC POS $ Sales, Immunity Category L52W as of 5/30/2020


Related content